Marco Pizzoferrato

Dr. Marco Pizzoferrato


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MMMaria Chiara Mentella
Maria Chiara Mentella
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
MPMarco Pizzoferrato
Marco Pizzoferrato
Antonio GasbarriniAntonio Gasbarrini
Antonio Gasbarrini
GMGIACINTO ABELE DONATO MIGGIANO
GIACINTO ABELE DONATO MIGGIANO
Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the gastrointestinal tract, characterized by an inflammatory process that requires lifelong treatment. The underlying causes of IBD are still unclear, as this heterogeneous disorder results from a complex interplay between genetic variability, the host immune system and environmental factors. The current knowledge recognizes diet as a risk factor for the development of IBD and attributes a substantial pathogenic role to the intestinal dysbiosis inducing an aberrant mucosal immune response in genetically predisposed individuals. This review focused on the clinical evidence available that considers the impact of some nutrients on IBD onset and the role of different diets in the management of IBD and their effects on the gut microbiota composition. The effects of the Specific Carbohydrate Diet, low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, gluten free diet, anti-inflammatory diet and Mediterranean diet are investigated with regard to their impact on microbiota and on the evolution of the disease. At present, no clear indications toward a specific diet are available but the assessment of dysbiosis prior to the recommendation of a specific diet should become a standard clinical approach in order to achieve a personalized therapy.

1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
VGViviana Gerardi
Viviana Gerardi
FMFrancesca Mangiola
Francesca Mangiola
LLLoris Riccardo Lopetuso
Loris Riccardo Lopetuso
MPMarco Pizzoferrato
Marco Pizzoferrato
AGAntonio Gasbarrini
Antonio Gasbarrini
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

1 October 2012 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
MPMarco Pizzoferrato
Marco Pizzoferrato
VGViviana Gerardi
Viviana Gerardi
LLLoris Lopetuso
Loris Lopetuso
AGAntonio Gasbarrini
Antonio Gasbarrini
The intestinal barrier serves 2 critical functions for the survival of the individual: first, it allows nutrient absorption and second, it defends the body from dangerous macromolecule penetration. It is a complex multilayer system, consisting of an external "anatomic" barrier and an inner "functional" immunological barrier. The interaction of these 2 barriers enables equilibrated permeability to be maintained. Many factors can alter this balance: gut microflora modifications, mucus layer alterations, and epithelial damage can increase intestinal permeability, allowing the translocation of luminal content to the inner layer of intestinal wall. Several techniques are now available that enable us to study gut permeability: "in vitro" models (Caco-2 and HT29-MTX cells) and "in vivo" not invasive tests (sugar tests and radioisotope scanning tests) are used to estimate permeability and to suggest molecular pathophysiological mechanisms of intestinal permeability in health and diseases. Many medicinal products used in the treatment of gastrointestinal diseases have also found to play an active role in modulate intestinal permeability: corticosteroids, 5-aminosalicylic acid, anti-tumor necrosis factor, probiotics, and mucosal protectors, like gelatin tannate. This review will particularly address the role of the gut barrier in maintaining intestinal permeability (microbiota, mucus, and epithelial cells), the techniques used for estimating intestinal permeability and the therapeutic approaches able to modify it.

1 January 2017 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
MPMarco Pizzoferrato
Marco Pizzoferrato
LLLoris Lopetuso
Loris Lopetuso
TMT. Musca
T. Musca
FIFabio Ingravalle
Fabio Ingravalle
AGA. Gasbarrini
A. Gasbarrini
Malnutrition is a major complication of inflammatory bowel disease (IBD). This mini review is focusing on main determinants of malnutrition in IBD, the most important components of malnutrition, including lean mass loss and sarcopenia, as an emerging problem. Each one of these components needs to be well considered in a correct nutritional evaluation of an IBD patient in order to build a correct multidisciplinary approach. The review is then focusing on possible instrumental and clinical armamentarium for the nutritional evaluation.

8 July 2011 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
MPMarco Pizzoferrato
Marco Pizzoferrato
FPFrancesca Romana Ponziani
Francesca Romana Ponziani
GGGiovanni Gasbarrini
Giovanni Gasbarrini
AGAntonio Gasbarrini
Antonio Gasbarrini

Verified
Journal Article
Open access
PDF file
CCCarlo Covello
Carlo Covello
FVFederica Di Vincenzo
Federica Di Vincenzo
GCGiovanni Cammarota
Giovanni Cammarota
MPMarco Pizzoferrato
Marco Pizzoferrato
Microplastics and nanoplastics (MNPs) are becoming an increasingly severe global problem due to their widespread distribution and complex impact on living organisms. Apart from their environmental impact, the effects of MNPs on living organisms have also continued to attract attention. The harmful impact of MNPs has been extensively documented in marine invertebrates and larger marine vertebrates like fish. However, the research on the toxicity of these particles on mammals is still limited, and their possible effects on humans are poorly understood. Considering that MNPs are commonly found in food or food packaging, humans are primarily exposed to them through ingestion. It would be valuable to investigate the potential harmful effects of these particles on gut health. This review focuses on recent research exploring the toxicological impacts of micro- and nanoplastics on the gut, as observed in human cell lines and mammalian models. Available data from various studies indicate that the accumulation of MNPs in mammalian models and human cells may result in adverse consequences, in terms of epithelial toxicity, immune toxicity, and the disruption of the gut microbiota. The paper also discusses the current research limitations and prospects in this field, aiming to provide a scientific basis and reference for further studies on the toxic mechanisms of micro- and nanoplastics.